GB9824091D0 - Biological materials and methods useful in the diagnosis and treatment of diseases - Google Patents

Biological materials and methods useful in the diagnosis and treatment of diseases

Info

Publication number
GB9824091D0
GB9824091D0 GBGB9824091.4A GB9824091A GB9824091D0 GB 9824091 D0 GB9824091 D0 GB 9824091D0 GB 9824091 A GB9824091 A GB 9824091A GB 9824091 D0 GB9824091 D0 GB 9824091D0
Authority
GB
United Kingdom
Prior art keywords
diagnosis
diseases
treatment
biological materials
methods useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9824091.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GBGB9824091.4A priority Critical patent/GB9824091D0/en
Publication of GB9824091D0 publication Critical patent/GB9824091D0/en
Priority to GB9925804A priority patent/GB2348203B/en
Priority to GB0113011A priority patent/GB2362385B/en
Priority to GB0205963A priority patent/GB2371049B/en
Priority to DE69943091T priority patent/DE69943091D1/en
Priority to EP99952693A priority patent/EP1127069B1/en
Priority to NZ511426A priority patent/NZ511426A/en
Priority to AT99952693T priority patent/ATE493435T1/en
Priority to PCT/GB1999/003617 priority patent/WO2000026238A2/en
Priority to AU64807/99A priority patent/AU773763B2/en
Priority to US09/431,887 priority patent/US6534036B1/en
Priority to JP2000579625A priority patent/JP2002531065A/en
Priority to CA002348751A priority patent/CA2348751A1/en
Priority to BR9915084-0A priority patent/BR9915084A/en
Priority to ARP990105585A priority patent/AR035004A1/en
Priority to ZA200103947A priority patent/ZA200103947B/en
Priority to US10/304,630 priority patent/US20030161836A1/en
Priority to ZA200301143A priority patent/ZA200301143B/en
Priority to US11/140,416 priority patent/US7875259B2/en
Priority to US11/974,794 priority patent/US20080241861A1/en
Ceased legal-status Critical Current

Links

GBGB9824091.4A 1998-11-04 1998-11-04 Biological materials and methods useful in the diagnosis and treatment of diseases Ceased GB9824091D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB9824091.4A GB9824091D0 (en) 1998-11-04 1998-11-04 Biological materials and methods useful in the diagnosis and treatment of diseases
GB9925804A GB2348203B (en) 1998-11-04 1999-11-01 Solube beta-forms of prion proteins, methods of preparation and use
GB0113011A GB2362385B (en) 1998-11-04 1999-11-01 Non-aggregated ß-forms of prion proteins
GB0205963A GB2371049B (en) 1998-11-04 1999-11-01 Methods of making antibodies against ß-forms of prion proteins and their uses
EP99952693A EP1127069B1 (en) 1998-11-04 1999-11-02 Method of making a monomeric beta-form of a prion protein
PCT/GB1999/003617 WO2000026238A2 (en) 1998-11-04 1999-11-02 Biological materials and methods useful in the diagnosis and treatment of prion diseases
BR9915084-0A BR9915084A (en) 1998-11-04 1999-11-02 Methods of producing a beta form of a prion protein, an antibody and a prion protein aggregate, of obtaining a non-aggregated concrete form of a prion protein and a binding agent, of detecting the presence of a non-aggregate in a biological sample. fibrillar and a prion protein, antibodies and a beta form of prion protein or its aggregate in a sample, to identify a substance, to prevent and / or treat a deprived disease, to diagnose a predisposition for the presence of a prion disease and detract from a biological sample, beta form of a prion protein, antibody, hybridoma cell, agent, non-fibrillary aggregate, uses of a binding agent, an aggregate and beta form of a prion protein, kit to diagnose a disease of primary, pharmaceutical composition and vaccine composition
NZ511426A NZ511426A (en) 1998-11-04 1999-11-02 Biological materials and methods useful in the diagnosis and treatment of diseases
AT99952693T ATE493435T1 (en) 1998-11-04 1999-11-02 METHOD FOR PRODUCING THE MONOMERIC BETA FORM OF A PRION PROTEIN
DE69943091T DE69943091D1 (en) 1998-11-04 1999-11-02 METHOD FOR PRODUCING THE MONOMERIC BETA FORM OF A PRION PROTEIN
AU64807/99A AU773763B2 (en) 1998-11-04 1999-11-02 Biological materials and methods useful in the diagnosis and treatment of diseases
US09/431,887 US6534036B1 (en) 1998-11-04 1999-11-02 Biological materials and methods useful in the diagnosis and treatment of diseases
JP2000579625A JP2002531065A (en) 1998-11-04 1999-11-02 Biological materials and methods useful in diagnosis and treatment of disease
CA002348751A CA2348751A1 (en) 1998-11-04 1999-11-02 Biological materials and methods useful in the diagnosis and treatment of diseases
ARP990105585A AR035004A1 (en) 1998-11-04 1999-11-04 A BETA FORM OF PRION PROTEIN, A METHOD FOR THEIR PREPARATION, A COMPOSITION THAT CONTAINS IT, USE OF THE SAME FOR THE MANUFACTURE OF A COMPOSITION, A MONOCLONAL ANTIBODY, A METHOD FOR THEIR PREPARATION, A HYBRIDOMA CELL, A LINK AGENT OF THE BETA FORM, A METHOD FOR YOUR PREPA
ZA200103947A ZA200103947B (en) 1998-11-04 2001-05-15 Biological materials and methods useful in the diagnosis and treatment of diseases.
US10/304,630 US20030161836A1 (en) 1998-11-04 2002-11-26 Biological materials and methods useful in the diagnosis and treatment of diseases
ZA200301143A ZA200301143B (en) 1998-11-04 2003-02-10 Biological materials and methods useful in the diagnosis and treatment of diseases.
US11/140,416 US7875259B2 (en) 1998-11-04 2005-05-27 Biological materials and methods useful in the diagnosis and treatment of diseases
US11/974,794 US20080241861A1 (en) 1998-11-04 2007-10-16 Biological materials and methods useful in the diagnosis and treatment of diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9824091.4A GB9824091D0 (en) 1998-11-04 1998-11-04 Biological materials and methods useful in the diagnosis and treatment of diseases

Publications (1)

Publication Number Publication Date
GB9824091D0 true GB9824091D0 (en) 1998-12-30

Family

ID=10841787

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9824091.4A Ceased GB9824091D0 (en) 1998-11-04 1998-11-04 Biological materials and methods useful in the diagnosis and treatment of diseases

Country Status (2)

Country Link
GB (1) GB9824091D0 (en)
ZA (2) ZA200103947B (en)

Also Published As

Publication number Publication date
ZA200103947B (en) 2003-02-17
ZA200301143B (en) 2003-10-29

Similar Documents

Publication Publication Date Title
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
ATE349428T1 (en) PROSTAGLAND INAGONISTS AND THEIR USE IN THE TREATMENT OF BONE DISEASES
IL205242A0 (en) Substituted oxazolidinones and their use in the field of blood coagulation
PT1083889E (en) TETRA-HYDROFOLANTALINE COMPOUNDS AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
EP0963219A4 (en) Manipulations of nitrosative and oxidatives stress in the treatment of disease
DE69805438D1 (en) MIXING AND CHARGING OPENING FOR MEDICAL TREATMENT
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
IL128894A0 (en) Materials and methods relating to the diagnosis and treatment of diabetes and obesity
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
AU6502199A (en) Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
NO20020207L (en) Biological materials and methods useful in the diagnosis and treatment of disease
DE69636367D1 (en) T-PA POLYMORPHISM AND ITS USE IN THE RISK DIAGNOSIS OF THROMBUS ASSOCIATED DISEASES
AU2001253886A1 (en) Methylxanthines in the diagnosis and treatment of autistic disorder
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
GB9509461D0 (en) DNA molecules and constructs and their use in the treatment of mastitis
GB0113011D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9824091D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB0205963D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9908059D0 (en) Diagnosis and treatment of diseases
GB9917878D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9906217D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
EP1023076A4 (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer
GB9917491D0 (en) Biological materials and methods useful in the diagnosis and treastment of diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)